***Thursday, April 22, 2021 at 2pm EDT*** Drive brand performance and patient outcomes by successfully deploying resources to engage cross-functional stakeholders. ***On demand available after final airing until Apr. 22, 2022***
Register free: https://www.pharmexec.com/pe_w/deployment
Event Overview:
Today’s commercial model is dependent upon orchestrated engagement which means thinking holistically about the stakeholders who are influencing brand performance. A winning brand strategy requires an understanding of market dynamics, including the type of product, the market environment, the disease, the access environment, the clinical attributes, physician knowledge of the disease, and more.
Innovative solutions incorporate analytics to create a dynamic deployment model that flexes with a changing market, while optimizing stakeholder interactions. Holistic solutions go beyond field sales deployment; it’s critical to consider the treatment journey and identify areas to enable stakeholders to make the best possible decisions to improve patient outcomes. Learn how deployment models built with agility and flexibility to scale up or pull back based on volume, geography, and market dynamics are driving productivity and effectiveness.
3 Key Take-aways:
Speakers: Tina Jovic, Sr. Director, Salesforce Services, IQVIA
Jen Millard, Vice President, Field Medical Affairs & Market Access Deployment Services, IQVIA
Robyn Stoy, Director, Patient Engagement, Contract Sales and Medical Solutions, IQVIA
Time and Date: Thursday, April 22, 2021 at 2pm EDT
On demand available after final airing until Apr. 22, 2022
Register free: https://www.pharmexec.com/pe_w/deployment
Streamlining the Path to Market for Novel Therapies: 5 Strategies for Success
October 15th 2021While advanced therapy medicinal products (ATMPs) hold great promise, the path to exploiting the technology has been challenging. Christian K. Schneider outlines the five strategies that must be considered to increase the success rates of development programs, while avoiding some of the common pitfalls.